-
公开(公告)号:WO2006124573A2
公开(公告)日:2006-11-23
申请号:PCT/US2006/018404
申请日:2006-05-12
发明人: TIDMARSH, George
IPC分类号: A61K31/704
CPC分类号: A61K31/704
摘要: The compound 2-deoxyglucose can be used to treat cancer and to improve patient outcome when administered at a therapeutically effective dose, and, optionally, co-administered with other anti-cancer drugs, or in combination with surgical resection or radiation therapy.
摘要翻译: 当以治疗有效剂量施用化合物2-脱氧葡萄糖时,可以用于治疗癌症并改善患者的结果,并且任选地与其它抗癌药物共同施用,或与手术切除或放射治疗组合。
-
公开(公告)号:WO2006065448A3
公开(公告)日:2006-10-26
申请号:PCT/US2005041959
申请日:2005-11-17
发明人: MATTEUCCI MARK , DUAN JIAN-XIN , RAO PHOTON
IPC分类号: A01N43/58 , A01N43/42 , A01N43/60 , A61K31/44 , A61K31/495 , A61K31/50 , C07D237/26 , C07D239/00 , C07D239/70 , C07D457/00 , C07D471/00 , C07D471/02 , C07D471/04 , C07D487/00 , C07D487/04 , C07D491/00 , C07D498/00 , C07D513/00 , C07D515/00
CPC分类号: C07D471/04 , C07D221/18 , C07D487/04 , C07D491/147 , C07D495/04
摘要: Compositions and methods for treating cancer and other hyperproliferatice disease conditions with topoisomerase inhibitors and their prodrugs are disclosed.
摘要翻译: 公开了用拓扑异构酶抑制剂及其前药治疗癌症和其他过度增殖疾病病症的组合物和方法。
-
公开(公告)号:WO2006071955A2
公开(公告)日:2006-07-06
申请号:PCT/US2005047314
申请日:2005-12-22
发明人: TIDMARSH GEORGE
IPC分类号: A61K31/165
CPC分类号: A61K31/165
摘要: Glufosfamide administered in combination with other chemotherapeutic agents is useful in cancer treatment.
摘要翻译: 与其他化学治疗剂组合施用的Glufosfamide可用于癌症治疗。
-
公开(公告)号:WO2006015191A2
公开(公告)日:2006-02-09
申请号:PCT/US2005/026929
申请日:2005-07-29
发明人: MATTEUCCI, Mark , RAO, Photon , DUAN, Jian-Xin
IPC分类号: A01N43/52
CPC分类号: C07D235/24 , C07D209/52 , C07D231/56 , C07D403/04 , C07D405/04 , C07D409/04 , C07D498/04
摘要: The invention provides lonidamine analogs as well as methods of treating cancer and BPH.
摘要翻译: 本发明提供了罗丹明胺类似物以及治疗癌症和BPH的方法。
-
公开(公告)号:WO2004064734A2
公开(公告)日:2004-08-05
申请号:PCT/US2004/001138
申请日:2004-01-16
发明人: TIDMARSH, George
IPC分类号: A61K
CPC分类号: A61K45/06 , A61K31/11 , A61K31/416 , A61K2300/00
摘要: Lonidamine or a lonidamine analog is administered with one or more additional anti-cancer agents or surgery or radiation to treat cancer or is administered alone or in combination to treat cancer, optionally in a sustained release formulation, and improve patient outcome.
摘要翻译: 给予罗丹明胺或兰尼达胺类似物与一种或多种另外的抗癌剂或手术或放射治疗癌症,或单独施用或组合施用,任选地在持续释放制剂中治疗癌症,并改善患者的结果。
-
公开(公告)号:WO03059149A3
公开(公告)日:2003-09-18
申请号:PCT/US0241339
申请日:2002-12-20
发明人: TIDMARSH GEORGE , MATTEUCCI MARK
IPC分类号: A61B20060101 , A61K49/00
CPC分类号: A61K49/0052 , A61K49/0021 , A61K49/0041
摘要: Methods are provided for cancer and pre-cancer detection by increased uptake of fluorophore glucose or deoxyglucose conjugates in cancerous and pre-cancerous cells relative to normal cells.
摘要翻译: 通过相对于正常细胞增加癌细胞和癌前细胞中荧光葡萄糖或脱氧葡萄糖缀合物的摄取来提供癌症和癌前检测的方法。
-
公开(公告)号:WO2003059149A2
公开(公告)日:2003-07-24
申请号:PCT/US2002/041339
申请日:2002-12-20
发明人: TIDMARSH, George , MATTEUCCI, Mark
IPC分类号: A61B
CPC分类号: A61K49/0052 , A61K49/0021 , A61K49/0041
摘要: Methods are provided for cancer and pre-cancer detection by increased uptake of fluorophore glucose or deoxyglucose conjugates in cancerous and pre-cancerous cells relative to normal cells.
摘要翻译: 通过相对于正常细胞增加癌细胞和癌前细胞中荧光团葡萄糖或脱氧葡萄糖结合物的摄取,为癌症和癌前检测提供了方法。
-
公开(公告)号:WO2016145092A1
公开(公告)日:2016-09-15
申请号:PCT/US2016/021581
申请日:2016-03-09
发明人: DUAN, Jian-Xin , CAO, Yeyu , CAI, Xiaohong , JIAO, Hailong , MA, Jing Yuan , MATTEUCCI, Mark
IPC分类号: A61P35/00 , A61K31/04 , A61K31/06 , A61K31/664
CPC分类号: C07F9/2466 , G01N33/57484 , G01N33/57496 , G01N2333/904 , G01N2800/52
摘要: Provided herein are compounds of formula I: wherein the variables are defined herein, processes of making them, and methods of treating cancer comprising administering such compounds.
摘要翻译: 本文提供了式I的化合物:其中变量在本文中定义,其制备方法和治疗癌症的方法包括施用此类化合物。
-
29.
公开(公告)号:WO2016081547A1
公开(公告)日:2016-05-26
申请号:PCT/US2015/061248
申请日:2015-11-18
申请人: MERCK PATENT GMBH , THRESHOLD PHARMACEUTICALS, INC. , ELENBAAS, Brian A. , GUALBERTO, Antonio , HART, Charles Praray
IPC分类号: A61K31/665 , A61K31/675 , A61K31/67 , C07F9/22 , A61P35/00
CPC分类号: A61K31/665 , A61K31/67 , A61K31/675 , C07F9/65062 , C07F9/65515 , C07F9/655345
摘要: Enolase levels are predictive of the probability that a cancer patient will respond favorably to cancer therapy involving administration of hypoxia-activated achiral phosphoramide mustards.
摘要翻译: 烯醇化酶水平预测癌症患者将有利地响应涉及施用缺氧激活的手性磷酰胺芥末的癌症治疗的可能性。
-
公开(公告)号:WO2016011195A1
公开(公告)日:2016-01-21
申请号:PCT/US2015/040642
申请日:2015-07-15
IPC分类号: C07F9/24 , A61K31/664 , A61P35/00
CPC分类号: C07F9/65062 , A61K31/664 , A61K31/675 , A61K45/06 , C07B2200/13 , A61K2300/00
摘要: The present invention provides a new method for making TH-302 and solid forms thereof. The compound in its solid form is an effective anti-cancer agent and may be used in various pharmaceutical compositions, and are particularly effective for the treatment of cancer. The invention also provides a method for preparing such compounds and forms and for treating cancer in a mammal comprising the step of administering a therapeutically effective amount of a solid form of TH-302 thereof.
摘要翻译: 本发明提供了一种制备TH-302及其固体形式的新方法。 其固体形式的化合物是有效的抗癌剂,可用于各种药物组合物中,并且对治疗癌症特别有效。 本发明还提供了一种制备这种化合物的方法以及用于治疗哺乳动物癌症的方法,包括施用治疗有效量的固体形式的TH-302的步骤。
-
-
-
-
-
-
-
-
-